Nexity (NXI)
Euronext Paris · France · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 4.696 |
|---|---|
| 52-week range | 4.310 – 10.450 |
| Return, 1 month / 3 months | −10.6% / −36.5% |
| Return, 1 year / 3 years | −53.7% / −64.4% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 40.0% |
| Worst drawdown (1 year) | -57.1% |
| Average daily value traded | 1.44M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nexity is a French real estate group based in Paris. It develops residential housing and neighbourhoods, and it runs estate agency networks that help households find homes. The company also provides property management services for apartment buildings and advises on urban development projects. Its customers include individual homebuyers, investors, local authorities and institutional clients, mainly in France, where it works across development, sales and management of residential and commercial property.
Nexity trades under the code NXI on the Euronext Paris in France, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Nexity (NXI) trades on the Euronext Paris in France. It last closed at EUR 4.696 on 19 October 2026.
Its price-based Market X-Ray is 29 out of 100 (a weak price profile), ranking 511 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 53.7% and over the last three months it fell 36.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 12 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -38.5% | ||
| From 52-week high | -54.2% | ||
| Momentum | 9 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -36.5% | ||
| 6-month return | -46.1% | ||
| 12-month return, skipping the last month | -48.2% | ||
| Stability (higher is calmer) | 35 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 40.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -57.1% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 1.44M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +2.0% |
|---|---|
| 1 month | −10.6% |
| 3 months | −36.5% |
| 6 months | −46.1% |
| 1 year | −53.7% |
| 3 years | −64.4% |
| 5 years | −85.5% |
Signals
| 50-day / 200-day average | 5.790 / 7.633 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.186 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 May 2023 | EUR 2.5000 |
| 23 May 2022 | EUR 2.5000 |
| 25 May 2021 | EUR 2.0000 |
| 25 May 2020 | EUR 2.0000 |
| 27 May 2019 | EUR 2.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.